Natera, Inc. NTRA Europe, Middle East, India, Africa — Total revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Natera, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Natera, Inc.'s europe, middle east, india, africa — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Natera, Inc.'s europe, middle east, india, africa — total revenues?
- Natera, Inc. (NTRA) reported europe, middle east, india, africa — total revenues of $6.43M in Q1 2026.
- How has Natera, Inc.'s europe, middle east, india, africa — total revenues changed year-over-year?
- Natera, Inc.'s europe, middle east, india, africa — total revenues increased by 6.2% year-over-year, from $6.05M to $6.43M.
- What does europe, middle east, india, africa — total revenues mean?
- This metric represents the total revenue generated by the company from diagnostic testing services and research collaborations within the Europe, Middle East, India, and Africa (EMEIA) geographic region. It reflects the company's ability to penetrate international markets, navigate diverse regulatory environments, and scale its proprietary molecular diagnostic technology outside of its primary domestic market. Growth in this segment indicates successful expansion of the global commercial footprint and adoption of genetic testing products in these specific territories.